180 related articles for article (PubMed ID: 35061104)
1. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies.
Sharma D; Singh NK
Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104
[TBL] [Abstract][Full Text] [Related]
2. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
Zhong S; Khalil RA
Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
[TBL] [Abstract][Full Text] [Related]
3. ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.
Yang H; Khalil RA
Adv Pharmacol; 2022; 94():255-363. PubMed ID: 35659374
[TBL] [Abstract][Full Text] [Related]
4. ADAMs family and relatives in cardiovascular physiology and pathology.
Zhang P; Shen M; Fernandez-Patron C; Kassiri Z
J Mol Cell Cardiol; 2016 Apr; 93():186-99. PubMed ID: 26522853
[TBL] [Abstract][Full Text] [Related]
5. Role of ADAM and ADAMTS disintegrin and metalloproteinases in normal pregnancy and preeclampsia.
Qu H; Khalil RA
Biochem Pharmacol; 2022 Dec; 206():115266. PubMed ID: 36191626
[TBL] [Abstract][Full Text] [Related]
6. ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview.
Takeda S
Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196928
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM function.
Liu H; Shim AH; He X
J Biol Chem; 2009 Oct; 284(42):29077-86. PubMed ID: 19692335
[TBL] [Abstract][Full Text] [Related]
8. Disintegrin and Metalloproteinases (ADAMs [A Disintegrin and Metalloproteinase] and ADAMTSs [ADAMs With a Thrombospondin Motif]) in Aortic Aneurysm.
Kilic T; Okuno K; Eguchi S; Kassiri Z
Hypertension; 2022 Jul; 79(7):1327-1338. PubMed ID: 35543145
[TBL] [Abstract][Full Text] [Related]
9. The ADAM metalloproteinases.
Edwards DR; Handsley MM; Pennington CJ
Mol Aspects Med; 2008 Oct; 29(5):258-89. PubMed ID: 18762209
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
Rocks N; Paulissen G; El Hour M; Quesada F; Crahay C; Gueders M; Foidart JM; Noel A; Cataldo D
Biochimie; 2008 Feb; 90(2):369-79. PubMed ID: 17920749
[TBL] [Abstract][Full Text] [Related]
11. Role of ADAM and ADAMTS metalloproteinases in airway diseases.
Paulissen G; Rocks N; Gueders MM; Crahay C; Quesada-Calvo F; Bekaert S; Hacha J; El Hour M; Foidart JM; Noel A; Cataldo DD
Respir Res; 2009 Dec; 10(1):127. PubMed ID: 20034386
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene.
Kuno K; Kanada N; Nakashima E; Fujiki F; Ichimura F; Matsushima K
J Biol Chem; 1997 Jan; 272(1):556-62. PubMed ID: 8995297
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.
Gerhardt S; Hassall G; Hawtin P; McCall E; Flavell L; Minshull C; Hargreaves D; Ting A; Pauptit RA; Parker AE; Abbott WM
J Mol Biol; 2007 Nov; 373(4):891-902. PubMed ID: 17897672
[TBL] [Abstract][Full Text] [Related]
14. A Disintegrin and Metalloproteases (ADAMs) in Cardiovascular, Metabolic and Inflammatory Diseases: Aspects for Theranostic Approaches.
van der Vorst EPC; Weber C; Donners MMPC
Thromb Haemost; 2018 Jul; 118(7):1167-1175. PubMed ID: 29874690
[TBL] [Abstract][Full Text] [Related]
15. ADAM-Integrin Interactions: potential integrin regulated ectodomain shedding activity.
Bridges LC; Bowditch RD
Curr Pharm Des; 2005; 11(7):837-47. PubMed ID: 15777238
[TBL] [Abstract][Full Text] [Related]
16. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
Schwettmann L; Wehmeier M; Jokovic D; Aleksandrova K; Brand K; Manns MP; Lichtinghagen R; Bahr MJ
J Hepatol; 2008 Aug; 49(2):243-50. PubMed ID: 18490073
[TBL] [Abstract][Full Text] [Related]
17. Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration.
Zigrino P; Steiger J; Fox JW; Löffek S; Schild A; Nischt R; Mauch C
J Biol Chem; 2007 Oct; 282(42):30785-93. PubMed ID: 17704059
[TBL] [Abstract][Full Text] [Related]
18. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
Flannery CR; Little CB; Caterson B; Hughes CE
Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
[TBL] [Abstract][Full Text] [Related]
19. Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions.
Eto K; Huet C; Tarui T; Kupriyanov S; Liu HZ; Puzon-McLaughlin W; Zhang XP; Sheppard D; Engvall E; Takada Y
J Biol Chem; 2002 May; 277(20):17804-10. PubMed ID: 11882657
[TBL] [Abstract][Full Text] [Related]
20. Matrix Metalloproteinases: How Much Can They Do?
Ågren MS; Auf dem Keller U
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
